SB Investment Advisers (UK)’s Zymergen Inc. Common Stock ZY Stock Holding History

SB Investment Advisers (UK)’s Portfolio ZY Stock Details ZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-26,614,219	Closed	-$74M	–	15
2022 Q3	$74M	Hold	26,614,219	–	–	0.57%	12
2022 Q2	$32.7M	Hold	26,614,219	–	–	0.26%	14
2022 Q1	$76.9M	Hold	26,614,219	–	–	0.36%	13
2021 Q4	$178M	Hold	26,614,219	–	–	0.52%	13
2021 Q3	$351M	Hold	26,614,219	–	–	1.09%	9
2021 Q2	$1.06B	Buy	+26,614,219	New	+$1.05B	2.09%	8

SB Investment Advisers (UK)'s ZY Position: Q4 2022 in Review

SB Investment Advisers (UK) sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 26,614,219 shares — an estimated $74M sold.

SB Investment Advisers (UK) first reported a position in ZY in Q2 2021 and held it in 6 quarters. The position peaked at $1.06B in Q2 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

SB Investment Advisers (UK) reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
SB Investment Advisers (UK) sold 26,614,219 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $74M.
SB Investment Advisers (UK) first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 6 quarters.
SB Investment Advisers (UK)'s Zymergen Inc. Common Stock position peaked at $1.06B in Q2 2021.
0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on SB Investment Advisers (UK)'s 13F filing for Q4 2022, filed 14 Feb 2023.